Literature DB >> 462379

A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.

C M Balch, S J Soong, T M Murad, A L Ingalls, W A Maddox.   

Abstract

Stage I melanoma encompasses an extraordinary diversity of biologic behavior. In such a setting where numerous parameters appear to influence survival, a multifactorial analysis using Cox's regression model is a valuable statistical model. Using a computerized data base of 394 clinical stage I melanoma patients treated at this institution during the past 20 years, a multifactorial analysis was used to compare the relative prognostic strength of 11 parameters. Two pathological factors (tumor thickness and ulceration) and two clinial factors (initial surgical treatment and anatomic location) were identified as the dominant prognostic variables. Other factors examined simultaneously that did not provide additional predictive influence on survival included the level of invasion, pigmentation, growth pattern, lymphocyte infiltration, pathological state, sex, and age. Melanoma thickness was the most important factor for predicting survival in patients with stage I melanoma (P less than 10(-8). This parameter is easy to measure and provides a quantitative estimate of clinically occult regional and distant metastases. Contrary to other reports using single factor analysis, the type of initial surgical treatment, in fact, did influence survival after other variables were taken into consideration. Thus the multifactorial analysis supports the observation that patients with intermediate thickness melanoma thickness of 1.5 to 3.99 mm had a 78% 8-year survival rate with wide excision of the melanoma and elective node dissection, while none survived more than 8 years if a melanoma of the same thickness was only widely excised. Multifactorial analysis is a useful and important statistical method when comparing treatment alternatives and prognostic factors in patients with melanoma.

Entities:  

Mesh:

Year:  1979        PMID: 462379

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  40 in total

1.  Gender-related differences in outcome for melanoma patients.

Authors:  Charles R Scoggins; Merrick I Ross; Douglas S Reintgen; R Dirk Noyes; James S Goydos; Peter D Beitsch; Marshall M Urist; Stephan Ariyan; Jeffrey J Sussman; Michael J Edwards; Anees B Chagpar; Robert C G Martin; Arnold J Stromberg; Lee Hagendoorn; Kelly M McMasters
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

Review 2.  Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute.

Authors:  Sanjay P Bagaria; Mark B Faries; Donald L Morton
Journal:  J Surg Oncol       Date:  2010-06-15       Impact factor: 3.454

3.  General surgery-important advances in clinical medicine: cutaneous melanoma.

Authors:  R J Thompson; B W Branson
Journal:  West J Med       Date:  1983-02

Review 4.  Lymph node dissection for melanoma: where do we stand?

Authors:  Madalyn G Neuwirth; Edmund K Bartlett; Giorgos C Karakousis
Journal:  Melanoma Manag       Date:  2017-03-03

5.  Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result.

Authors:  Edward L Jones; Teresa S Jones; Nathan W Pearlman; Dexiang Gao; Robert Stovall; Csaba Gajdos; Nicole Kounalakis; Rene Gonzalez; Karl D Lewis; William A Robinson; Martin D McCarter
Journal:  JAMA Surg       Date:  2013-05       Impact factor: 14.766

6.  Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat.

Authors:  C L Day; T J Harrist; F Gorstein; A J Sober; R A Lew; R J Friedman; B S Pasternack; A W Kopf; T B Fitzpatrick; M C Mihm
Journal:  Ann Surg       Date:  1981-07       Impact factor: 12.969

7.  Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.

Authors:  C M Balch; S J Soong; A A Bartolucci; M M Urist; C P Karakousis; T J Smith; W J Temple; M I Ross; W R Jewell; M C Mihm; R L Barnhill; H J Wanebo
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

8.  Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression.

Authors:  H J Wanebo; P H Cooper; R W Hagar
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

9.  Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma.

Authors:  R W Griffiths; J C Briggs
Journal:  Ann R Coll Surg Engl       Date:  1985-03       Impact factor: 1.891

10.  Anorectal malignant melanoma has a poor prognosis.

Authors:  P M Antoniuk; J J Tjandra; B W Webb; R E Petras; J W Milsom; V W Fazio
Journal:  Int J Colorectal Dis       Date:  1993-07       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.